Shorter hepatic transit time can suggest coming metastases: Through-monitoring by contrast-enhanced ultrasonography?

Journal of Ultrasound in Medicine

Volumn 29, Issue 5, 2010, Pages 719-726

  Zhang, Huiping ^a   He, Yingqian ^a   Du, Lianfang ^a   Wu, Ying ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Contrast enhanced ultrasonography; Hepatic transit time; Liver metastasis

Indexed keywords

COMPUTERIZED TOMOGRAPHY; MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATIENT TREATMENT; TUMORS; ULTRASONOGRAPHY;

CONTRAST-ENHANCED ULTRASONOGRAPHY; CONTROL GROUPS; HEALTHY CONTROLS; HEPATIC ARTERY; LIVER METASTASIS; MALIGNANT TUMORS; STATISTICAL DIFFERENCES; TRANSIT TIME;

LIVER;

CONTRAST AGENT BR1; CONTRAST MEDIUM; DIAGNOSTIC AGENT; PHOSPHOLIPID; SULFUR HEXAFLUORIDE;

ARTICLE; CARCINOMA; ECHOGRAPHY; FEMALE; HUMAN; LIVER; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

CARCINOMA; CONTRAST MEDIA; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE;

EID: 77951957172     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2010.29.5.719     Document Type: Article

References (26)

1. Bryant TH, Blomley MJ, Albrecht T, et al. Improved characterization of liver lesions with liver-phase uptake of liverspecific microbubbles: prospective multicenter study. Radiology 2004; 232:799-809.
2. Lencioni R, European Federation of Societies for Ultrasound in Medicine and Biology. Impact of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) guidelines on the use of contrast agents in liver ultrasound. Eur Radiol 2006; 16:1610-1613.
3. Bernatik T, Strobel D, Häusler J, Hahn EG, Becker D. Hepatic transit time of an ultrasound echo enhancer indicating the presence of liver metastases: first clinical results. Ultraschall Med 2002; 23:91-95.
4. Haendl T, Strobel D, Steinebrunner N, Frieser M, Hahn EG, Bernatik T. Hepatic transit time in benign liver lesions. Ultraschall Med 2008; 29:184-189.
5. Zhou JH, Li AH, Cao LH, et al. Haemodynamic parameters of the hepatic artery and vein can detect liver metastases: assessment using contrast-enhanced ultrasound. Br J Radiol 2008; 81:113-119.
6. Pedersen JF, Larsen VA, Bytzer P, Madsen LG, Hamberg O. Hepatic transit time of ultrasound contrast in biopsy characterized liver disease. Acta Radiol 2005; 46:557-560.
7. Sugimoto H, Kaneko T, Hirota M, Tezel E, Nakao A. Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis. J Hepatol 2002; 37:578-583.
8. Lim AK, Taylor-Robinson SD, Patel N, et al. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut 2005; 54:128-133.
9. Blomley MJ, Lim AK, Harvey CJ, et al. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study. Gut 2003; 52:1188-1193.
10. Chinese Society of Lemology and Parasitology, Chinese Society of Hepatology. The guideline of prevention and therapy for virus hepatitis. Chin J Hepatol 2000; 8:324-329.
11. Penna C, Nordlinger B. Surgery of liver metastases from colorectal cancer: new promises. Br Med Bull 2002; 64:127-140.
12. Penna C, Nordlinger B. Colorectal metastasis (liver and lung). Surg Clin North Am 2002; 82:1075-1090.
13. Gerber HP, Ferrara N. Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies. Cancer Res 2005; 65:671-680.
14. Sweeney CJ, Miller KD, Sledge GW Jr. Resistance in the anti-angiogenic era: nay-saying or a word of caution? Trends Mol Med 2003; 9:24-29.
15. Leen E, Ceccotti P, Moug SJ, et al. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection? Ann Surg 2006; 243:236-240.
16. Abdelmoumene A, Chevallier P, Chalaron M, et al. Detection of liver metastases under 2 cm: comparison of different acquisition protocols in four row multidetector-CT (MDCT). Eur Radiol 2005; 15:1881-1887.
17. Patel NA, Roh MS. Utility of intraoperative liver ultrasound. Surg Clin North Am 2004; 84:513-524.
18. Leen E, Angerson WJ, Wotherspoon H, Moule B, Cooke TG, McArdle CS. Comparison of the Doppler perfusion index and intraoperative ultrasonography in diagnosing colorectal liver metastases: evaluation with postoperative follow-up results. Ann Surg 1994; 220:663-667.
19. Kojima H, Tanigawa N, Komemushi A, Kariya S, Sawada S. Computed tomography perfusion of the liver: assessment of pure portal blood flow studied with CT perfusion during superior mesenteric arterial portography. Acta Radiol 2004; 45:709-715.
20. Abdullah SS, Pialat JB, Wiart M, et al. Characterization of hepatocellular carcinoma and colorectal liver metastasis by means of perfusion MRI. J Magn Reson Imaging 2008; 28:390-395.
21. Cuenod C, Leconte I, Siauve N, et al. Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. Radiology 2001; 218:556-561.
22. Lim AK, Patel N, Eckersley RJ, et al. Hepatic vein transit time of SonoVue: a comparative study with Levovist. Radiology 2006; 240:130-135.
23. Bernatik T, Becker D, Neureiter D, et al. Hepatic transit time of an echo enhancer: an indicator of metastatic spread to the liver. Eur J Gastroenterol Hepatol 2004; 16:313-317.
24. Bang N, Nielsen MB, Rasmussen AN, Osterhammel PA, Pedersen JF. Hepatic vein transit time of an ultrasound contrast agent: simplified procedure using pulse inversion imaging. Br J Radiol 2001; 74:752-755.
25. Liu Y, Matsui O. Changes of intratumoral microvessels and blood perfusion during establishment of hepatic metastases in mice. Radiology 2007; 243:386-395.
26. Natsume T, Okazumi S, Takayama W, et al. Evaluation of the hepatic blood flow increase in the cases with liver metastasis and prediction of patent cases of liver metastasis using dynamic CT. Hepatogastroenterology 2007; 54:1745-1747.